Progress in understanding melanoma propagation

par Shackleton, Mark, Quintana, Elsa
Publié 2010

Personalised surveillance after treatment for high-risk cancer

par Guo, Christina, Lewin, Jeremy, Shackleton, Mark
Publié dans Oncotarget (2019)

An update on adjuvant systemic therapies in melanoma

par Samuel, Evangeline, Moore, Maggie, Voskoboynik, Mark, Shackleton, Mark, Haydon, Andrew
Publié dans Melanoma Manag (2019)

Efficient tumor formation by single human melanoma cells

par Quintana, Elsa, Shackleton, Mark, Sabel, Michael S., Fullen, Douglas R., Johnson, Timothy M., Morrison, Sean J.
Publié 2008

Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series

par Banks, Patricia D., Lasocki, Arian, Lau, Peter K. H., Sandhu, Shahneen, McArthur, Grant, Shackleton, Mark
Publié dans Health Sci Rep (2019)

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

par Quintana, Elsa, Shackleton, Mark, Foster, Hannah R., Fullen, Douglas R., Sabel, Michael S., Johnson, Timothy M., Morrison, Sean J.
Publié 2010

Human melanoma metastasis in NSG mice correlates with clinical outcome in patients

par Quintana, Elsa, Piskounova, Elena, Shackleton, Mark, Weinberg, Daniel, Eskiocak, Ugur, Fullen, Douglas R., Johnson, Timothy M., Morrison, Sean J.
Publié dans Sci Transl Med (2012)

Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads

par Schröder, Jan, Hsu, Arthur, Boyle, Samantha E., Macintyre, Geoff, Cmero, Marek, Tothill, Richard W., Johnstone, Ricky W., Shackleton, Mark, Papenfuss, Anthony T.
Publié 2014

Physiological Levels of Pik3ca (H1047R) Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors

par Tikoo, Anjali, Roh, Vincent, Montgomery, Karen G., Ivetac, Ivan, Waring, Paul, Pelzer, Rebecca, Hare, Lauren, Shackleton, Mark, Humbert, Patrick, Phillips, Wayne A.
Publié 2012

Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review

par Blood, Zachary, Tran, Anh, Caleo, Lauren, Saw, Robyn, Dieng, Mbathio, Shackleton, Mark, Soyer, H Peter, Arnold, Chris, Mann, Graham J, Morton, Rachael L
Publié dans BMJ Open (2021)

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells

par Carter, Christoph C., McNamara, Lucy A., Onafuwa-Nuga, Adewunmi, Shackleton, Mark, Riddell, James, Bixby, Dale, Savona, Michael R., Morrison, Sean J., Collins, Kathleen L.
Publié 2011

Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma

par Eskiocak, Ugur, Ramesh, Vijayashree, Gill, Jennifer G., Zhao, Zhiyu, Yuan, Stacy W., Wang, Meng, Vandergriff, Travis, Shackleton, Mark, Quintana, Elsa, Johnson, Timothy M., DeBerardinis, Ralph J., Morrison, Sean J.
Publié dans Nat Commun (2016)

Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma

par Eskiocak, Ugur, Ramesh, Vijayashree, Gill, Jennifer G., Zhao, Zhiyu, Yuan, Stacy W., Wang, Meng, Vandergriff, Travis, Shackleton, Mark, Quintana, Elsa, Frankel, Arthur E., Johnson, Timothy M., DeBerardinis, Ralph J., Morrison, Sean J.
Publié dans Nat Commun (2016)

Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression

par Puzanov, Igor, Amaravadi, Ravi K., McArthur, Grant A., Flaherty, Keith T., Chapman, Paul B., Sosman, Jeffrey A., Ribas, Antoni, Shackleton, Mark, Hwu, Patrick, Chmielowski, Bartosz, Nolop, Keith B., Lin, Paul S., Kim, Kevin B.
Publié dans Eur J Cancer (2015)

Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome

par Tan, Lih Yin, Mintoff, Chris, Johan, M. Zahied, Ebert, Brenton W., Fedele, Clare, Zhang, You Fang, Szeto, Pacman, Sheppard, Karen E., McArthur, Grant A., Foster-Smith, Erwin, Ruszkiewicz, Andrew, Brown, Michael P., Bonder, Claudine S., Shackleton, Mark, Ebert, Lisa M.
Publié dans Oncotarget (2016)

Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

par Lynch, Fiona A, Katona, Lynda, Jefford, Michael, Smith, Allan Ben, Shaw, Joanne, Dhillon, Haryana M, Ellen, Steve, Phipps-Nelson, Jo, Lai-Kwon, Julia, Milne, Donna, Russell, Lahiru, Dax, Victoria, Diggens, Justine, Kent, Holly, Button-Sloan, Alison, Elliott, Jane, Shackleton, Mark, Burridge, Hayley, Ftanou, Maria
Publié dans J Clin Med (2020)

Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi

par Robertson, Susan J., Orme, Lisa, Teixeira, Rodrigo, Shamassi, Maryam, Newell, Felicity, Patch, Ann-Marie, Yeh, Iwei, Gard, Grace, Wilmott, James, Jackett, Louise, LeBoit, Philip, Fellowes, Andrew, MacArthur, Grant, Fox, Stephen, Hayward, Nicholas K., Bastian, Boris, Scolyer, Richard, Waddell, Nicola, Penington, Anthony, Shackleton, Mark
Publié dans JAMA Dermatol (2021)

MDM4 is a key therapeutic target in cutaneous melanoma

par Gembarska, Agnieszka, Luciani, Flavie, Fedele, Clare, Russell, Elisabeth A, Dewaele, Michael, Villar, Stéphanie, Zwolinska, Aleksandra, Haupt, Sue, de Lange, Job, Yip, Dana, Goydos, James, Haigh, Jody J, Haupt, Ygal, Larue, Lionel, Jochemsen, Aart, Shi, Hubing, Moriceau, Gatien, Lo, Roger S, Ghanem, Ghanem, Shackleton, Mark, Bernal, Federico, Marine, Jean-Christophe
Publié 2012

A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis

par Ebert, Lisa M., Tan, Lih Y., Johan, M. Zahied, Min, Kay Khine Myo, Cockshell, Michaelia P., Parham, Kate A., Betterman, Kelly L., Szeto, Paceman, Boyle, Samantha, Silva, Lokugan, Peng, Angela, Zhang, YouFang, Ruszkiewicz, Andrew, Zannettino, Andrew C. W., Gronthos, Stan, Koblar, Simon, Harvey, Natasha L., Lopez, Angel F., Shackleton, Mark, Bonder, Claudine S.
Publié dans Angiogenesis (2016)

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

par Davis, Ian D., Chen, Weisan, Jackson, Heather, Parente, Phillip, Shackleton, Mark, Hopkins, Wendie, Chen, Qiyuan, Dimopoulos, Nektaria, Luke, Tina, Murphy, Roger, Scott, Andrew M., Maraskovsky, Eugene, McArthur, Grant, MacGregor, Duncan, Sturrock, Sue, Tai, Tsin Yee, Green, Simon, Cuthbertson, Andrew, Maher, Darryl, Miloradovic, Lena, Mitchell, Susan V., Ritter, Gerd, Jungbluth, Achim A., Chen, Yao-Tseng, Gnjatic, Sacha, Hoffman, Eric W., Old, Lloyd J., Cebon, Jonathan S.
Publié 2004